Literature DB >> 8898478

Prevalence of pneumococcal serotypes in invasive diseases in southern India.

T J John1, R Pai, M K Lalitha, M V Jesudason, K N Brahmadathan, G Sridharan, M C Steinhoff.   

Abstract

Forty two pneumococcal strains obtained in Vellore, Tamil Nadu, from 42 patients with invasive diseases, namely pneumonia, meningitis, or peritonitis were typed. Over one-third of pneumococci in children and nearly half in adults were serotype followed by serogroups/types 5, 6 and 7 which were most common in children and adults taken together. These 4 serogroups/types accounted for 11 (79%) of 14 strains in children and 20 (71%) of 28 strains in adults. The remaining 11 strains belonged to 8 serogroups/types, namely 3, 4, 10, 11, 12, 13, 19 and 20.

Entities:  

Mesh:

Year:  1996        PMID: 8898478

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  4 in total

1.  Persistence of two invasive Streptococcus pneumoniae clones of serotypes 1 and 5 in comparison to that of multiple clones of serotypes 6B and 23F among children in southern Israel.

Authors:  N Porat; R Trefler; R Dagan
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

Review 2.  The current status of community-acquired pneumonia management and prevention in children under 5 years of age in India: a review.

Authors:  Krishna Kumar Yadav; Shally Awasthi
Journal:  Ther Adv Infect Dis       Date:  2016-07-04

3.  Dissemination of a chloramphenicol- and tetracycline-resistant but penicillin-susceptible invasive clone of serotype 5 Streptococcus pneumoniae in Colombia.

Authors:  M Tamayo; R Sá-Leão; I Santos Sanches; E Castañeda; H de Lencastre
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

4.  Invasive pneumococcal infections in Vellore, India: clinical characteristics and distribution of serotypes.

Authors:  Viktor Molander; Camilla Elisson; Veeraraghavan Balaji; Erik Backhaus; James John; Rosemol Vargheese; Ranjith Jayaraman; Rune Andersson
Journal:  BMC Infect Dis       Date:  2013-11-09       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.